AbbVie Wants Hypertension Drug Antitrust Row Sent To NJ
AbbVie Inc. and other pharmaceutical companies told a New York federal court Friday that lawsuits alleging they paid off competitors to delay generic competition for blood pressure drug Bystolic should be...To view the full article, register now.
Already a subscriber? Click here to view full article